نتائج البحث

Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example

• Authors : Emma Warren; Belinda J. C. Castles; Gillian C. Sharratt

Subjects: Economic modeling; Cost-effectiveness; Health technology assessment

• Source: Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 549-564 (2024)

تفاصيل العنوان

Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China

• Authors : Rui Hua; Fei Kong; Guangming Li

Subjects: Alfosbuvir; Daclatasvir; Hepatitis C virus

• Source: Infectious Diseases and Therapy, Vol 12, Iss 11, Pp 2595-2609 (2023)

تفاصيل العنوان

Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations

• Authors : Dwaipayan Mukherjee; Michelle Collins; Douglas E. Dylla

Subjects: CYP3A4; Drug–drug interactions; Hepatitis C virus

• Source: Infectious Diseases and Therapy, Vol 12, Iss 8, Pp 2057-2070 (2023)

تفاصيل العنوان

Achieving Hepatitis C Micro-Elimination in Chinese Injecting Drug Users: A Dynamic Network Modeling Study.

• Authors : Chen Y; Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, 241 Huaihai West Road, Shanghai, 200030, China.; Bao Y

• Source: Infectious diseases and therapy [Infect Dis Ther] 2025 Jan; Vol. 14 (1), pp. 181-197. Date of Electronic Publication: 2024 Dec 11.Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229

تفاصيل العنوان

Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment.

• Authors : Wróblewska A; Laboratory of Molecular Diagnostics, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Abrahama 58, 80-307, Gdansk, Poland.; Gliwiński M

• Source: Infectious diseases and therapy [Infect Dis Ther] 2025 Jan; Vol. 14 (1), pp. 305-315. Date of Electronic Publication: 2024 Dec 26.Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229

تفاصيل العنوان

Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China

• Authors : Kailu Fang; Hong-liang Wang; Yushi Lin

Subjects: Hepatitis C virus; Harm reduction; Modeling

• Source: Infectious Diseases and Therapy, Vol 12, Iss 4, Pp 1043-1055 (2023)

تفاصيل العنوان

Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need

• Authors : Bidell, Monique R; McLaughlin, Milena; Faragon, John

Subjects: Medical Microbiology; Biomedical and Clinical Sciences; Liver Disease

• Source: Infectious Diseases and Therapy. 5(3)

تفاصيل العنوان

Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia

• Authors : Anja De Weggheleire; Irith De Baetselier; Sokkab An

Subjects: Diagnostic methods; Genotyping; Hepatitis C

• Source: Infectious Diseases and Therapy, Vol 9, Iss 3, Pp 657-667 (2020)

تفاصيل العنوان

Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection

• Authors : Amy Puenpatom; Yumei Cao; Xian Yu

Subjects: Hepatitis C; Liver fibrosis; Real-world

• Source: Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 355-365 (2020)

تفاصيل العنوان

A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients

• Authors : Patel, Nimish; Nasiri, Mona; Koroglu, Arden

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Clinical Research

• Source: Infectious Diseases and Therapy. 4(1)

تفاصيل العنوان